ESR1 and neoplasm: Our studies have demonstrated no relationship between intensity of AT-1R expression and some clinicopathological parameters, i.e. grade of malignancy, primary tumour size, presence of lymph node metastases, menopausal status or expression of ER, PR and HER2 receptors.